Click to return to home page

About IMS Global Services

IMS provide the answers

IMS provide Market Insight

Industry events, conferences and links

Our complete product range

Latest news and press releases

Addresses, phone numbers and emails

 

 


Therapeutic Categories offering Megabrand Potential

According to Lehman Brothers, not every therapeutic category lends itself to megabrand potential. The key drivers are as follows:

  • Medical Need (chronic as opposed to acute)
  • Population Size (the larger the better)
  • Pricing Potential

The greatest opportunity to prescribe is for conditions where the patient base is large and seeking treatment. This tends to involve diseases with obvious symptoms, particularly involving pain, and includes categories such as cancer, osteoporosis, hypercholesterolemia, rheumatoid arthritis and thrombosis, in descending order of importance.

01 Feb 2000, Copyright IMS HEALTH

See Also: Definition of Megabrand
Recent Blockbuster History
AstraZeneca's Potential Megabrands
Positioning of small Companies with the 'Megabrand Scenario'
The Trend Towards Megabrands
External links:

<< Back to Market Insight